Plain-English translation of NCT07136415 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
United States
Phase
Post-approval monitoring
Sponsor
Brigham and Women's Hospital
Collaborators
Patient-Centered Outcomes Research Institute, University of Pittsburgh
Enrollment target
~1,000 participants
Started
February 2026
Primary completion
February 2031
Age range
40 Years – 62 Years
Sex
Female only
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sharon Ng, MS
Brigham and Women's Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.